Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | +9,900.00% |
2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P Global BMI Index | CI |
2022 | Kaleido Biosciences, Inc.(NasdaqGS:KLDO) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2020 | 0.98 | Sales 2021 | 1.1 | Capitalization | 102M |
---|---|---|---|---|---|
Net income 2020 | -81M | Net income 2021 | -90M | EV / Sales 2020 | 309,973,492 x |
Net cash position 2020 | 25.21M | Net cash position 2021 | 16.78M | EV / Sales 2021 | 77,011,319 x |
P/E ratio 2020 |
-3.73
x | P/E ratio 2021 |
-1.11
x | Employees | 76 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-07-10 | |
Jean K. Mixer
BRD | Director/Board Member | 57 | 19-09-29 |
Anthony Quinn
BRD | Director/Board Member | 62 | 16-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.0001 | 0.00% | 462 |
24-04-17 | 0.0001 | 0.00% | 305 |
24-04-16 | 0.0001 | 0.00% | 285 |
24-04-15 | 0.0001 | 0.00% | 605 |
24-04-12 | 0.0001 | 0.00% | 500 |
Delayed Quote OTC Markets, April 17, 2024 at 03:35 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 4.26K | |
-1.78% | 41.36B | |
+44.81% | 41.3B | |
+4.01% | 39.61B | |
-15.14% | 25.62B | |
+3.16% | 24.09B | |
-24.08% | 18.38B | |
-2.67% | 11.82B | |
+24.76% | 11.85B | |
+7.01% | 11.07B |
- Stock Market
- Equities
- KLDO Stock